Skip to main content
. 2021 Aug 13;3(8):e0513. doi: 10.1097/CCE.0000000000000513

Table 1.

Patient Characteristics, Clinical Symptoms, Imaging Findings, Treatment, and Outcome

Characteristics Total Cohort (n = 15)
Age, median (range) 68 (25–85)
Sex, female, n (%) 8 (53)
Presenting signs
 Impaired consciousness 7
 Focal neurologic deficit 10
 Seizure 2
Procedure
 Lung biopsy 5
 Chest tube placement and/or lavage 3
 Removal jugular central venous catheter 2
 Direct arterial introduction of air 2
 Direct venous introduction of air 1
 Bronchoscopy 1
 Gastroscopy 1
Seizure, n (%) 11 (73)
Acute imaging, n (%) 14 (93)
 CT 13
 MRI 1
Findings acute imaging
 Intracranial air 10
 Focal edema 3
 Ischemia 1
Treatment with HBOT, n (%) 14 (93)
Sedation and invasive ventilation, n (%) 6 (40)
 Before HBOT 5
 After HBOT 1
Findings follow-up imaging, n (%) 9 (60)
 Focal edema 3
 Ischemia 6
 None 2
Medication
 Benzodiazepine, n (%) 6 (55)
 AED, n (%) 10 (91)
  Levetiracetam 9
  Valproic acid 2
  Phenytoin 1
Recurrent seizures at follow-up 0
AED at follow-up, n (%) 4 (27)

AED = anti-epileptic drug, HBOT = hyperbaric oxygen therapy.

Modified Rankin Scale: 0 no symptoms, 1 no significant disability, 2 slight disability but functional independence, 3 moderate disability requiring some assistance, 4 moderately severe disability requiring assistance for walking and bodily needs, 5 severe disability requiring constant care, and 6 dead.